Hemo Organic [HEMORGANIC] vs Innova Captab [INNOVACAP] Detailed Stock Comparison

Hemo Organic

BSE
Loading...

Innova Captab

NSE
Loading...

TLDR: Quick Comparison Summary

Based on 19 vital metrics comparison: Hemo Organic wins in 6 metrics, Innova Captab wins in 11 metrics, with 0 ties. Innova Captab appears stronger overall.

View Metrics Details

Vital Metrics Comparison

MetricHemo OrganicInnova CaptabBetter
P/E Ratio (TTM)44.8737.87Innova Captab
Price-to-Book Ratio-21.725.12Hemo Organic
Debt-to-Equity Ratio-9.7735.24Hemo Organic
PEG Ratio0.027.22Hemo Organic
EV/EBITDA184.5327.17Innova Captab
Profit Margin (TTM)3.28%9.98%Innova Captab
Operating Margin (TTM)-6,026.32%11.68%Innova Captab
EBITDA Margin (TTM)N/A11.68%N/A
Return on Equity-108.18%13.37%Innova Captab
Return on Assets (TTM)3.29%8.12%Innova Captab
Free Cash Flow (TTM)$-3.62M$-1.09BHemo Organic
1-Year Return-20.17%8.33%Innova Captab
Price-to-Sales Ratio (TTM)1.443.78Hemo Organic
Enterprise Value$47.24M$51.82BInnova Captab
EV/Revenue Ratio1.903.98Hemo Organic
Gross Profit Margin (TTM)26.32%37.21%Innova Captab
Revenue per Share (TTM)$7$227Innova Captab
Earnings per Share (Diluted)$0.23$22.65Innova Captab
Beta (Stock Volatility)-0.06N/AN/A
Performance
News Sentiment
Key Stats
Valuation
Financials
Short Interest
Dividends

Hemo Organic vs Innova Captab Stock Performance Analysis

Loading Price Chart...

Hemo Organic
Innova Captab
Hemo Organic Stock Overview | Innova Captab Stock Overview

Performance Comparison

Short-term Returns

Stock1D1W1M3M6MYTD
Hemo Organic-9.83%-2.42%-4.34%-11.05%-0.75%-18.99%
Innova Captab0.41%0.17%-4.49%3.01%-1.92%-22.38%

Long-term Returns

Stock1Y3Y5Y10Y15Y20Y
Hemo Organic-20.17%-59.74%-20.17%-56.11%-92.59%39.04%
Innova Captab8.33%59.05%59.05%59.05%59.05%59.05%

News Based Sentiment: Hemo Organic vs Innova Captab

Hemo Organic

News sentiment data is not available for Hemo Organic at this time.

Innova Captab

News based Sentiment: MIXED

September brought a mix of positive developments – a new facility, strong quarterly results – alongside regulatory challenges with the NPPA fixing drug prices. While the company shows strong growth potential, these pricing controls introduce uncertainty and warrant a 'mixed' sentiment, making it a significant month for investors to assess the company's future trajectory.

View Innova Captab News Sentiment Analysis

Performance & Financial Health Analysis: Hemo Organic vs Innova Captab

MetricHEMORGANICINNOVACAP
Market Information
Market Cap i₹33.48M₹49.37B
Market Cap CategorySmall capSmall cap
10 Day Avg. Volume i3,94748,888
90 Day Avg. Volume i2,54045,067
Last Close₹9.26₹861.10
52 Week Range₹8.05 - ₹13.70₹662.00 - ₹1,260.00
% from 52W High-32.41%-31.66%
All-Time High₹2,386.00 (Apr 21, 2008)₹1,260.00 (Jan 06, 2025)
% from All-Time High-99.61%-31.66%
Growth Metrics
Quarterly Revenue Growth-1.00%0.20%
Quarterly Earnings GrowthN/A0.05%
Financial Health
Profit Margin (TTM) i0.03%0.10%
Operating Margin (TTM) i-60.26%0.12%
Return on Equity (TTM) i-1.08%0.13%
Debt to Equity (MRQ) i-9.7735.24
Cash & Liquidity
Book Value per Share (MRQ)₹-0.44₹167.66
Cash per Share (MRQ)₹0.03₹11.41
Operating Cash Flow (TTM) i₹-38,918,000₹282.88M
Levered Free Cash Flow (TTM) i₹1.64M₹1.28B
Dividends
Last 12-Month Dividend Yield iN/AN/A
Last 12-Month Dividend iN/AN/A

Valuation & Enterprise Metrics Analysis: Hemo Organic vs Innova Captab

MetricHEMORGANICINNOVACAP
Price Ratios
P/E Ratio (TTM) i44.8737.87
Forward P/E iN/A20.69
PEG Ratio i0.027.22
Price to Sales (TTM) i1.443.78
Price to Book (MRQ) i-21.725.12
Market Capitalization
Market Capitalization i₹33.48M₹49.37B
Enterprise Value i₹47.24M₹51.82B
Enterprise Value Metrics
Enterprise to Revenue i1.903.98
Enterprise to EBITDA i184.5327.17
Risk & Other Metrics
Beta i-0.06N/A
Book Value per Share (MRQ) i₹-0.44₹167.66

Financial Statements Comparison: Hemo Organic vs Innova Captab

Financial Metrics

Loading Financial Charts...

Revenue

EBITDA

Shareholders Equity

Operating Margin

Free Cash Flow

Long Term Debt

Profit Margin

Current Ratio

Operating Cash Flow

Income Statement (MRQ)

Metric (MRQ)HEMORGANICINNOVACAP
Revenue/Sales i₹19,000₹3.52B
Cost of Goods Sold i₹14,000₹2.21B
Gross Profit i₹5,000₹1.31B
Research & Development iN/AN/A
Operating Income (EBIT) i₹-1.15M₹410.54M
EBITDA i₹-1.14M₹565.82M
Pre-Tax Income i₹-1.15M₹426.77M
Income Tax i₹-288,000₹116.62M
Net Income (Profit) i₹-857,000₹310.15M

Balance Sheet & Liquidity Metrics (MRQ)

Metric (MRQ)HEMORGANICINNOVACAP
Cash & Equivalents i₹87,000₹155.19M
Total Current Assets i₹46.94M₹7.03B
Total Current Liabilities i₹36.47M₹3.53B
Long-Term Debt i₹14.80M₹2.45B
Total Shareholders Equity i₹-1.52M₹9.59B
Retained Earnings iN/A₹4.53B
Property, Plant & Equipment i₹20,000₹442.93M

Cash Flow Statement Comparison (MRQ)

Metric (MRQ)HEMORGANICINNOVACAP
Operating Cash Flow iN/A₹378.60M
Capital Expenditures iN/A₹-1.21B
Free Cash Flow iN/A₹-908.56M
Debt Repayment iN/A₹-7.69M
Common Stock Repurchase iN/AN/A

Short Interest & Institutional Ownership Analysis

MetricHEMORGANICINNOVACAP
Shares Short iN/AN/A
Short Ratio iN/AN/A
Short % of Float iN/AN/A
Average Daily Volume (10 Day) i3,94748,888
Average Daily Volume (90 Day) i2,54045,067
Shares Outstanding i3.47M57.22M
Float Shares i1.92M15.70M
% Held by Insiders i0.42%0.72%
% Held by Institutions i0.00%0.19%

Dividend Analysis & Yield Comparison: Hemo Organic vs Innova Captab

MetricHEMORGANICINNOVACAP
Last 12-Month Dividend iN/AN/A
Last 12-Month Dividend Yield iN/AN/A
3-Year Avg Annual Dividend iN/AN/A
3-Year Avg Dividend Yield iN/AN/A
3-Year Total Dividends iN/AN/A
Ex-Dividend DateN/AN/A